Continuous MPTP intoxication in the Göttingen minipig results in chronic parkinsonian deficits

MS Nielsen, AN Glud, A Møller, P Mogensen… - Acta neurobiologiae …, 2016 - vbn.aau.dk
Parkinson's disease (PD) is a common neurodegenerative disorder, resulting from
progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNc) …

Neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced animal models of Parkinson's disease

J Kasahara, ME Choudhury, N Nishikawa… - Animal models for the …, 2017 - Elsevier
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by a
slowly progressive motor dysfunction and loss of dopaminergic neurons located in the …

Toxicity of MPTP on neurotransmission in three mouse models of Parkinson's disease

S Pain, A Gochard, S Bodard, Z Gulhan… - Experimental and …, 2013 - Elsevier
Parkinson's disease (PD) is recognized as the second most common neurodegenerative
disorder after Alzheimer's disease. PD is mainly characterized by a selective degeneration …

[HTML][HTML] Proposed motor scoring system in a porcine model of Parkinson's disease induced by chronic subcutaneous injection of MPTP

JH Moon, JH Kim, HJ Im, DS Lee, EJ Park… - Experimental …, 2014 - ncbi.nlm.nih.gov
Destruction of dopaminergic neurons in the substantia nigra pars compacta (SNpc) is a
common pathophysiology of Parkinson's disease (PD). Characteristics of PD patients …

The MPTP mouse model: cues on DA release and neural stem cell restorative role

PA Serra, S Pluchino, B Marchetti, MS Desole… - Parkinsonism & related …, 2008 - Elsevier
1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) is known to cause parkinsonism in
humans and this fact is a major incentive for using this toxin as an animal model to study the …

Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine)-induced mouse model of Parkinson's disease

H Yokoyama, H Kuroiwa, J Kasahara, T Araki - Acta neurobiologiae …, 2011 - ane.pl
Parkinson's disease (PD) is a common neurodegenerative disease that appears essentially
as a sporadic condition. PD is well known to be a chronic and progressive …

Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease

GJ Masilamoni, Y Smith - Journal of Neural Transmission, 2018 - Springer
Parkinson's disease (PD) is a progressive neurodegenerative disorder clinically
characterized by cardinal motor deficits including bradykinesia, tremor, rigidity and postural …

[HTML][HTML] MPTP-induced mouse model of Parkinson's disease: A promising direction for therapeutic strategies

M Mustapha, CNM Taib - Bosnian journal of basic medical …, 2021 - ncbi.nlm.nih.gov
Among the popular animal models of Parkinson's disease (PD) commonly used in research
are those that employ neurotoxins, especially 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine …

Unexpected toxicity of very low dose MPTP in mice: A clue to the etiology of P arkinson's disease?

S Dovero, C Gross, E Bezard - Synapse, 2016 - Wiley Online Library
Although much progress have been made in recent years, the etiology of idiopathic
Parkinson's disease remains obscure. The chance discovery that injection of the neurotoxin …

Motor neurons pathology after chronic exposure to MPTP in mice

G Vivacqua, F Biagioni, CL Busceti, M Ferrucci… - Neurotoxicity …, 2020 - Springer
Abstract The neurotoxin 1-methyl, 4-phenyl-1, 2, 3, 6-tetrahydropiridine (MPTP) is widely
used to produce experimental parkinsonism in rodents and primates. Among different …